This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Irm LLC. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Christine Dierks: Innovator in Hedgehog Pathway Modulation
Introduction
Christine Dierks is a notable inventor based in Freiburg, Germany. She has made significant contributions to the field of biochemistry, particularly in the modulation of the hedgehog signaling pathway. Her innovative work has implications for addressing various aberrant growth states.
Latest Patents
Christine Dierks holds a patent for "Biphenylcarboxamide derivatives as hedgehog pathway modulators." This invention provides a method for modulating the activity of the hedgehog signaling pathway. Specifically, it offers a way to inhibit aberrant growth states resulting from phenotypes such as Ptc loss-of-function, hedgehog gain-of-function, smoothened gain-of-function, or Gli gain-of-function. The method involves contacting a cell with a sufficient amount of a compound of Formula I.
Career Highlights
Throughout her career, Christine has worked with prominent companies in the pharmaceutical industry, including Irm LLC and Novartis AG. Her experience in these organizations has allowed her to develop her expertise in drug development and signaling pathways.
Collaborations
Christine has collaborated with notable professionals in her field, including Markus Warmuth and Xu Wu. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Christine Dierks is a pioneering inventor whose work in hedgehog pathway modulation has the potential to impact therapeutic strategies for various growth disorders. Her contributions to the field exemplify the importance of innovation in addressing complex biological challenges.